USE OF ulipristal TREATMENT Uterine Fibroids

• 收藏
• 分享

专利权人:

THE U.S.A. AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES;LABORATOIRE HRA PHARMA

发明人:

GAINER, ERIN,ULMANN, ANDRE,BLITHE, DIANA,NIEMAN, LYNNETTE

申请号：

DK09706347

公开号：

DK2252301T3

申请日:

2009.01.28

申请国别(地区):

DK

年份:

2014

代理人:

摘要：

The invention relates to a method for treating uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17±-acetoxy-11²-[4- N , N -dimethylamino-phenyl)-19-norpregna- 4, 9-diene-3, 20-dione (ulipristal acetate) or any metabolite thereof. More particularly, the method is useful for reducing or stopping bleeding in a patient afflicted with uterine fibroids, and/or for reducing the size of uterine fibroids.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/